Société Citius Pharmaceuticals, Inc.
Actions
CTXR
US17322U2078
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,82 USD | -3,53 % | +9,95 % | +8,39 % |
Métier
Nombre d'employés: 22
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Leonard Mazur
CEO | Chief Executive Officer | 79 | 01/07/13 |
Jaime Bartushak
DFI | Director of Finance/CFO | 57 | 27/11/17 |
Preeti Singh
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/22 |
Myron Czuczman
CTO | Chief Tech/Sci/R&D Officer | 65 | 14/07/20 |
Alan Lader
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/16 |
Gary Talarico
COO | Chief Operating Officer | 69 | 01/03/16 |
Myron Holubiak
BRD | Director/Board Member | 77 | 01/10/15 |
Ilanit Allen
IRC | Investor Relations Contact | - | 17/05/21 |
General Counsel | - | 10/02/22 | |
Paul Sowyrda
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Myron Holubiak
BRD | Director/Board Member | 77 | 01/10/15 |
Dennis McGrath
BRD | Director/Board Member | 67 | 07/02/23 |
Leonard Mazur
CEO | Chief Executive Officer | 79 | 01/07/13 |
Carol Webb
BRD | Director/Board Member | 78 | 01/03/16 |
Suren Dutia
BRD | Director/Board Member | 82 | 01/10/15 |
Eugene Holuka
BRD | Director/Board Member | 65 | 01/06/16 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 180 673 355 | 168 365 416 ( 93,19 %) | 0 | 93,19 % |
Coordonnées société
Citius Pharmaceuticals, Inc.
11 Commerce Drive 1st floor
07016, Cranford
+908 967 6677
http://www.citiuspharma.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+8,39 % | 148 M | |
+24,74 % | 47,54 Md | |
-0,47 % | 41,96 Md | |
+43,96 % | 41,55 Md | |
+25,40 % | 30,36 Md | |
+17,96 % | 27,61 Md | |
-4,47 % | 28,7 Md | |
+50,73 % | 14,7 Md | |
+42,56 % | 13,51 Md | |
+1,46 % | 12,34 Md |
- Bourse
- Actions
- Action CTXR
- Société Citius Pharmaceuticals, Inc.